Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.63 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.57 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.56 |
| ▸ | GLP1R | P43220 | 3/20 | 0.54 |
| ▸ | ECE1 | P42892 | 1/20 | 0.54 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30165222 | 0.96 | TFPI (0.61) | TFPIKEAP1VIPR1VIPR2 | |
| Nerinetide SCHEMBL29371548 | 0.95 | TFPI (0.65) | TFPIKEAP1VIPR1VIPR2GLP1R | |
| SCHEMBL30220503 | 0.94 | TFPI (0.66) | TFPIKEAP1VIPR1VIPR2GLP1R | |
| SCHEMBL30658586 | 0.91 | TFPI (0.67) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL29702365 | 0.89 | TFPI (0.78) | TFPIVIPR1VIPR2GLP1R | |
| SCHEMBL30629356 | 0.88 | VIPR1 (0.71) | TFPIKEAP1VIPR1VIPR2GLP1R | |
| SCHEMBL29489273 | 0.87 | TFPI (0.73) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL29519384 | 0.87 | TFPI (0.68) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL29409598 | 0.87 | TFPI (0.61) | TFPIVIPR1VIPR2GLP1RECE1 | |
| SCHEMBL29702470 | 0.87 | TFPI (0.54) | TFPIKEAP1VIPR1VIPR2GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085038-A | Polypeptide with therapeutic effect on kidney injury and application thereof | 傅文侠 | 2024-05-28 | — | — | CN | disclosed |